Halozyme Therapeutics Inc (HALO) — Financial Flexibility Index
Halozyme Therapeutics Inc (HALO) has a Financial Flexibility Index of 0.11x as of September 2025. Free cash flow of $181.63 Million (operating CF $178.60 Million minus capex $3.03 Million) represents 0% of total liabilities ($1.72 Billion). Also explore Halozyme Therapeutics Inc (HALO) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Halozyme Therapeutics Inc Financial Flexibility Index (2001–2024)
Historical Financial Flexibility Index trend for Halozyme Therapeutics Inc across 24 annual periods. Check Halozyme Therapeutics Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Halozyme Therapeutics Inc (2001–2024)
Year-by-year free cash flow to debt coverage for Halozyme Therapeutics Inc. For the full company profile including market capitalisation, see market value of Halozyme Therapeutics Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.29x | $489.76 Million | $479.06 Million | $1.70 Billion | ▲ +17.7% |
| 2023 | 0.24x | $403.87 Million | $388.57 Million | $1.65 Billion | ▲ +67.1% |
| 2022 | 0.15x | $244.92 Million | $240.11 Million | $1.67 Billion | ▼ -55.8% |
| 2021 | 0.33x | $300.90 Million | $299.44 Million | $907.48 Million | ▲ +145.4% |
| 2020 | 0.14x | $57.96 Million | $55.45 Million | $428.88 Million | ▲ +178.7% |
| 2019 | -0.17x | $-81.38 Million | $-85.42 Million | $474.11 Million | ▲ +26.7% |
| 2018 | -0.23x | $-44.84 Million | $-49.50 Million | $191.36 Million | ▼ -153.9% |
| 2017 | 0.43x | $135.40 Million | $134.05 Million | $311.58 Million | ▲ +370.4% |
| 2016 | -0.16x | $-47.25 Million | $-50.38 Million | $294.00 Million | ▲ +35.8% |
| 2015 | -0.25x | $-34.72 Million | $-37.08 Million | $138.79 Million | ▲ +32.4% |
| 2014 | -0.37x | $-46.15 Million | $-47.52 Million | $124.62 Million | ▲ +4.1% |
| 2013 | -0.39x | $-47.04 Million | $-49.34 Million | $121.78 Million | ▲ +47.3% |
| 2012 | -0.73x | $-62.92 Million | $-64.33 Million | $85.87 Million | ▼ -19.9% |
| 2011 | -0.61x | $-33.52 Million | $-34.35 Million | $54.86 Million | ▲ +3.0% |
| 2010 | -0.63x | $-44.74 Million | $-45.39 Million | $70.99 Million | ▼ -14.4% |
| 2009 | -0.55x | $-38.69 Million | $-40.15 Million | $70.25 Million | ▲ +1.5% |
| 2008 | -0.56x | $-34.21 Million | $-35.37 Million | $61.18 Million | ▼ -1252.2% |
| 2007 | 0.05x | $2.22 Million | $-147.66K | $45.69 Million | ▼ -85.0% |
| 2006 | 0.32x | $7.44 Million | $7.08 Million | $23.01 Million | ▲ +105.9% |
| 2005 | -5.49x | $-12.65 Million | $-13.00 Million | $2.30 Million | ▼ -15.8% |
| 2004 | -4.74x | $-7.49 Million | $-7.72 Million | $1.58 Million | ▼ -257.1% |
| 2003 | -1.33x | $-49.73K | $-49.73K | $37.45K | ▲ +75.2% |
| 2002 | -5.35x | $-55.78K | $-55.78K | $10.43K | ▲ +48.8% |
| 2001 | -10.45x | $-34.37K | $-34.37K | $3.29K | — |